15001967Kennedy MJ, Scripture CD, Kashuba AD, Scott CS, Gaedigk A, Kearns GLClinical pharmacology and therapeuticsArylamine N-Acetyltransferase; Cystic Fibrosis; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Xanthine OxidaseChild; Child, Preschool; Confidence Intervals; Female; Humans; MaleKennedy MJ, Scripture CD, Kashuba AD, Scott CS, Gaedigk A, Kearns GL. Activities of cytochrome P450 1A2, N-acetyltransferase 2, xanthine oxidase, and cytochrome P450 2D6 are unaltered in children with cystic fibrosis. Clin Pharmacol Ther. 2004 Mar; 75(3):163-71.Clin Pharmacol Ther2004-03-01T00:00:002004Activities of cytochrome P450 1A2, N-acetyltransferase 2, xanthine oxidase, and cytochrome P450 2D6 are unaltered in children with cystic fibrosis.cmhprofilesont:personsuffixperson suffixFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD008297Physiology11633280.54802MaleAuthorship 18550.0622160.0622161authors10.2511has subject areaD014969Chemicals & Drugs2140.997053Xanthine OxidaseD016001Concepts & Ideas10120.996874Confidence IntervalsD019388Chemicals & Drugs2120.997554Cytochrome P-450 CYP1A2D019389Chemicals & Drugs91830.831211Cytochrome P-450 CYP2D61ProfessorPediatricsResearchPhD, MSAndreaGaedigkAndrea Gaedigk39.08346750000000-94.577112900000001Gaedigk, Andrea0000-0001-6968-1893Director, Pharmacogenetics Core LaboratoryChildren's Mercy Kansas CityD001191Chemicals & Drugs4180.995386Arylamine N-Acetyltransferasetrue1Director, Pharmacogenetics Core LaboratoryDirector, Pharmacogenetics Core LaboratoryD002648Living Beings11632570.520082ChildD002675Living Beings10415030.693171Child, PreschoolD003550Disorders12180.974123Cystic FibrosisD005260Physiology11835990.534568FemaleD006801Living Beings12067970.397999Humans